Armistice Capital »

Bausch Lomb Corp shares owned by Armistice Capital

Quarter-by-quarter ownership of Bausch Lomb Corp (BLCO) shares owned by Armistice Capital from 13F filings

Historical chart of Armistice Capital investment in Bausch Lomb Corp

Tip: Access up to 7 years of quarterly data

All positions including Bausch Lomb Corp held by Armistice Capital consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Bausch Lomb Corp by Armistice Capital

Quarter filed Position value Share count Share price at filing
2026-06-30 $878k 53k 16.56

More positions owned by Armistice Capital

State Str Spdr S&p 500 Etf T Tr Unit Put Option (SPY)
Ishares Tr Russell 2000 Etf Put Option (IWM)
Cytokinetics Com New (CYTK)
Agios Pharmaceuticals (AGIO)
Madrigal Pharmaceuticals (MDGL)
Ptc Therapeutics I (PTCT)
Supernus Pharmaceuticals (SUPN)
Travere Therapeutics (TVTX)
Immunovant (IMVT)
Incyte Corporation (INCY)
Neurocrine Biosciences (NBIX)
UnitedHealth (UNH)
Mineralys Therapeutics (MLYS)
Freshpet (FRPT)
Dyne Therapeutics (DYN)

View all positions for Armistice Capital

Top funds holding Bausch Lomb Corp

Carl C. Icahn, Individual
Oaktree Capital Management
Deutsche Bank Aktiengesellschaft
D. E. Shaw & Co
Davidson Kempner Capital Management
GoldenTree Asset Management
Caspian Capital
Glenview Captal Management
Arrowstreet Capital, Limited Partnership
T. Rowe Price Associates
Citadel Advisors
Clark Estates
Morgan Stanley
Clearline Capital
Whitebox Advisors

View all funds holding Bausch Lomb Corp